OPDP ramp-up spawns new letter warning Vanda for omitted risks by Beth Snyder Bulik Thursday, November 1, 2018 The FDA's promo police issued their 7th official reprimand this year—and its third this month—to Vanda Pharmaceutical for webpage infractions.
Aka-what? Vanda puts spotlight on antipsychotic side effect by Beth Snyder Bulik Monday, August 14, 2017 Fanapt maker Vanda has launched a national TV awareness campaign about akathisia, a little-known side effect of some schizophrenia drugs.
